have indicated that histone deacetylase (HDAC) inhibitors are promising agents for the treatment of cancer. With the aim to search for novel potentHDACinhibitors, we designed and synthesized two series of hydroxamates and 2-aminobenzamides compounds as HDACinhibitors and antitumor agents. Those compounds were investigated for their HDAC enzymatic inhibitory activities and in vitro anti-proliferation
Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors
作者:Thales Kronenberger、Glaucio Monteiro Ferreira、Alfredo Danilo Ferreira de Souza、Soraya da Silva Santos、Antti Poso、João Augusto Ribeiro、Maurício Temotheo Tavares、Fernando Rogério Pavan、Gustavo Henrique Goulart Trossini、Marcio Vinícius Bertacine Dias、Roberto Parise-Filho
DOI:10.1016/j.bmc.2020.115600
日期:2020.8
analogue development by bioisosterism/retro-bioisosterism, which resulted in 20 new substituted 3-benzoic acid derivatives. Compounds were active against MtDHFR, with IC50 values ranging from 7 to 40 μM, where compound 4e not only had the best inhibitory activity (IC50 = 7 μM), but also was 71-fold more active than the original fragment MB872. The 4e inhibition kinetics indicated an uncompetitive mechanism